Tonghua Dongbao Pharmaceutical Co Ltd (600867) — Capital Reinvestment Ratio
Tonghua Dongbao Pharmaceutical Co Ltd (600867) has a Capital Reinvestment Ratio of 2.39x as of September 2025, meaning it reinvests 2% of its operating cash flow (CN¥62.99 Million) in capital expenditures (CN¥150.58 Million). Check Tonghua Dongbao Pharmaceutical Co Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Tonghua Dongbao Pharmaceutical Co Ltd Capital Reinvestment Ratio (2000–2025)
This chart tracks Tonghua Dongbao Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 25 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Tonghua Dongbao Pharmaceutical Co Ltd.
Annual Capital Reinvestment Ratio for Tonghua Dongbao Pharmaceutical Co Ltd (2000–2025)
Year-by-year Capital Reinvestment Ratio for Tonghua Dongbao Pharmaceutical Co Ltd from 2000 to 2025. See Tonghua Dongbao Pharmaceutical Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.75x | CN¥689.23 Million | CN¥517.69 Million | ▼ -39.3% |
| 2024 | 1.24x | CN¥459.74 Million | CN¥568.73 Million | ▲ +206.1% |
| 2023 | 0.40x | CN¥861.52 Million | CN¥348.13 Million | ▼ -29.1% |
| 2022 | 0.57x | CN¥863.09 Million | CN¥491.63 Million | ▲ +7.6% |
| 2021 | 0.53x | CN¥1.13 Billion | CN¥600.75 Million | ▲ +31.6% |
| 2020 | 0.40x | CN¥1.19 Billion | CN¥479.59 Million | ▲ +58.1% |
| 2019 | 0.25x | CN¥1.15 Billion | CN¥293.13 Million | ▼ -71.1% |
| 2018 | 0.88x | CN¥876.94 Million | CN¥773.07 Million | ▲ +356.8% |
| 2017 | 0.19x | CN¥961.19 Million | CN¥185.50 Million | ▼ -66.0% |
| 2016 | 0.57x | CN¥725.76 Million | CN¥411.53 Million | ▼ -58.3% |
| 2015 | 1.36x | CN¥294.58 Million | CN¥400.09 Million | ▲ +163.6% |
| 2014 | 0.52x | CN¥205.89 Million | CN¥106.08 Million | ▼ -40.2% |
| 2013 | 0.86x | CN¥221.06 Million | CN¥190.36 Million | ▼ -30.8% |
| 2012 | 1.24x | CN¥194.32 Million | CN¥241.83 Million | ▲ +174.7% |
| 2010 | 0.45x | CN¥160.40 Million | CN¥72.66 Million | ▼ -4.8% |
| 2009 | 0.48x | CN¥166.20 Million | CN¥79.07 Million | ▼ -22.5% |
| 2008 | 0.61x | CN¥92.31 Million | CN¥56.67 Million | ▼ -71.3% |
| 2007 | 2.14x | CN¥120.94 Million | CN¥258.34 Million | ▲ +17.6% |
| 2006 | 1.82x | CN¥158.00 Million | CN¥286.90 Million | ▲ +40.3% |
| 2005 | 1.29x | CN¥92.23 Million | CN¥119.38 Million | ▼ -65.3% |
| 2004 | 3.73x | CN¥13.17 Million | CN¥49.08 Million | ▲ +193.0% |
| 2003 | 1.27x | CN¥45.51 Million | CN¥57.90 Million | ▼ -54.5% |
| 2002 | 2.79x | CN¥31.99 Million | CN¥89.41 Million | ▲ +270.9% |
| 2001 | 0.75x | CN¥117.73 Million | CN¥88.69 Million | ▼ -58.2% |
| 2000 | 1.80x | CN¥29.12 Million | CN¥52.46 Million | — |